FMP

FMP

Enter

ICCC - ImmuCell Corpor...

photo-url-https://financialmodelingprep.com/image-stock/ICCC.png

ImmuCell Corporation

ICCC

NASDAQ

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

3.61 USD

-0.09 (-2.49%)

About

ceo

Mr. Michael F. Brigham

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement mar...

CIK

0000811641

ISIN

US4525253062

CUSIP

452525306

Address

56 Evergreen Drive

Phone

207 878 2770

Country

US

Employee

75

IPO Date

May 5, 1987

ICCC Financial Summary

CIK

0000811641

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

452525306

ISIN

US4525253062

Country

US

Price

3.61

Beta

0.56

Volume Avg.

39.69k

Market Cap

28.28M

Shares

-

52-Week

3.34-5.59

DCF

-4.81

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-6.94

P/B

-

Website

https://immucell.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest ICCC News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep